The CML blast crisis cell line K562, harboring a BCR-ABL1 fusion mutation, and the eosinophilic leukemia cell line EOL-1 (harboring a FIP1L1-PDGFRA mutation), were treated with crenolanib as described above. The gene discussed is BCR; the disease is Chronic Eosinophilic Leukemia, Not Otherwise Specified.